Valthos builds next-generation biodefense. The company harnesses computational methods to characterize biological sequences and design adaptive countermeasures, helping government and life sciences stakeholders respond to emerging threats with speed and precision.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/29/25 | $30,000,000 | Seed |
Founders Fund Lux Capital OpenAI Startup Fund | undisclosed |
